Kala Pharmaceuticals, Inc. (KALA): Price and Financial Metrics

Kala Pharmaceuticals, Inc. (KALA)

Today's Latest Price: $7.18 USD

0.19 (-2.58%)

Updated Nov 24 4:00pm

Add KALA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

KALA Stock Summary

  • Kala Pharmaceuticals Inc's stock had its IPO on July 20, 2017, making it an older stock than just 11.22% of US equities in our set.
  • With a price/sales ratio of 79.29, Kala Pharmaceuticals Inc has a higher such ratio than 96.62% of stocks in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for KALA comes in at -34.76% -- higher than that of just 10.26% of stocks in our set.
  • Stocks that are quantitatively similar to KALA, based on their financial statements, market capitalization, and price volatility, are VIVE, QUOT, TWOU, CNTG, and CTSO.
  • KALA's SEC filings can be seen here. And to visit Kala Pharmaceuticals Inc's official web site, go to www.kalarx.com.

KALA Stock Price Chart Interactive Chart >

Price chart for KALA

KALA Price/Volume Stats

Current price $7.18 52-week high $14.68
Prev. close $7.37 52-week low $3.60
Day low $7.04 Volume 1,382,500
Day high $7.47 Avg. volume 1,214,759
50-day MA $7.75 Dividend yield N/A
200-day MA $9.15 Market Cap 402.62M

Kala Pharmaceuticals, Inc. (KALA) Company Bio

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles technology. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was founded in 2009 and is based in Waltham, Massachusetts.

KALA Latest News Stream

Event/Time News Detail
Loading, please wait...

KALA Latest Social Stream

Loading social stream, please wait...

View Full KALA Social Stream

Latest KALA News From Around the Web

Below are the latest news stories about Kala Pharmaceuticals Inc that investors may wish to consider to help them evaluate KALA as an investment opportunity.

Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q2 2020 Results - Earnings Call Transcript

Kala Pharmaceuticals, Inc. (KALA) Q2 2020 Earnings Conference Call August 06, 2020, 08:00 AM ET Company Participants Niranjan Kameswaran - SVP, Strategy Mary Reumuth - CFO Mark Iwicki - Chairman, President and CEO Kim Brazzell - Chief Medical Officer Todd Bazemore - COO Hongming Chen - Chief Scientific Officer Conference...

SA Transcripts on Seeking Alpha | August 8, 2020

Kala Pharmaceuticals EPS misses by $0.01, beats on revenue

Kala Pharmaceuticals (KALA): Q2 GAAP EPS of -$0.42 misses by $0.01.Revenue of $0.83M (-59.7% Y/Y) beats by $0.14M.Press Release...

Seeking Alpha | August 6, 2020

Kala Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report second quarter 2020 financial results on Thursday, August 6, 2020. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:00 a.m. ET.

Yahoo | July 30, 2020

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).

Yahoo | July 17, 2020

Hedge Funds Have Never Been This Bullish On Kala Pharmaceuticals, Inc. (KALA)

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]

Yahoo | June 23, 2020

Read More 'KALA' Stories Here

KALA Price Returns

1-mo -6.99%
3-mo -18.59%
6-mo -41.67%
1-year 73.85%
3-year -64.84%
5-year N/A
YTD 94.58%
2019 -24.54%
2018 -73.55%
2017 N/A
2016 N/A
2015 N/A

Continue Researching KALA

Want to see what other sources are saying about Kala Pharmaceuticals Inc's financials and stock price? Try the links below:

Kala Pharmaceuticals Inc (KALA) Stock Price | Nasdaq
Kala Pharmaceuticals Inc (KALA) Stock Quote, History and News - Yahoo Finance
Kala Pharmaceuticals Inc (KALA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9871 seconds.